Authors: Kvinnsland, S Anker, G Dirix, LY Bonneterre, J Prove, AM Wilking, N Lobelle, JP Mariani, O di Salle, E Polli, A Massimini, G

Citation: S. Kvinnsland et al., High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatment, EUR J CANC, 36(8), 2000, pp. 976-982

Authors: Kaufmann, M Bajetta, E Dirix, LY Fein, LE Jones, SE Cervek, J Fowst, C Polli, A Di Salle, E Massimini, G Piscitelli, G

Citation: M. Kaufmann et al., Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen: results of a double-blind randomised phase III trial, EUR J CANC, 36, 2000, pp. S86-S87

Authors: Kaufmann, M Bajetta, E Dirix, LY Fein, LE Jones, SE Zilembo, N Dugardyn, JC Nasurdi, C Mennel, RG Cervek, J Fowst, C Polli, A di Salle, E Arkhipov, A Piscitelli, G Miller, LL Massimini, G

Citation: M. Kaufmann et al., Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: Results of a phase III randomized double-blind trial, J CL ONCOL, 18(7), 2000, pp. 1399-1411

Authors: Lonning, PE Bajetta, E Murray, R Tubiana-Hulin, M Eisenberg, PD Mickiewicz, E Celio, L Pitt, P Mita, M Aaronson, NK Fowst, C Arkhipov, A di Salle, E Polli, A Massimini, G

Citation: Pe. Lonning et al., Activity of exemestane in metastatic breast cancer after failure of nonsteroidal aromatase inhibitors: A phase II trial, J CL ONCOL, 18(11), 2000, pp. 2234-2244

Authors: Jones, S Vogel, C Arkhipov, A Fehrenbacher, L Eisenberg, P Cooper, B Honig, S Polli, A Whaley, F di Salle, E Tiffany, J Consonni, A Miller, L

Citation: S. Jones et al., Multicenter, phase II trial of exemestane as third-line hormonal therapy of postmenopausal women with metastatic breast cancer, J CL ONCOL, 17(11), 1999, pp. 3418-3425

Authors: Polli, A

Citation: A. Polli, Active vision - Controlling sound with eye movements, LEONARDO, 32(5), 1999, pp. 405-411